Ohr Pharmaceutical, Inc. 10-Q



Exhibit 32.2



Certification of Chief Financial Officer

Pursuant to 18 U.S.C Section 1350,

As Adopted Pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002


Not Filed Pursuant to the Securities Exchange Act of 1934


In connection with the Quarterly Report of Ohr Pharmaceutical, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof  (the “Report”), I, Sam Backenroth , Chief Financial Officer, of the Company , certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: May 11, 2012


/s/ Sam Backenroth  
Name:  Sam Backenroth  
Title:  Interim Chief Financial Officer